HAEMONETICS CORP/MASS (HAE) Stock Earnings Estimates
USA - New York Stock Exchange - NYSE:HAE - US4050241003 - Common Stock
68.82 USD
-1.2 (-1.71%)
68.82 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.169B 17.67% | 1.309B 12.01% | 1.361B 3.95% | 1.331B -2.19% | 1.409B 5.86% | 1.515B 7.52% | |
| EBITDA YoY % growth | 261.5M 31.87% | 310.449M 18.72% | 360.834M 16.23% | 441.58M 22.38% | 451.46M 2.24% | 491.7M 8.91% | |
| EBIT YoY % growth | 168.2M 67.20% | 213.234M 26.77% | 245.248M 15.01% | 348.26M 42.00% | 382.58M 9.85% | 418.76M 9.46% | |
| Operating Margin | 14.39% | 16.29% | 18.02% | 26.17% | 27.15% | 27.64% | |
| EPS YoY % growth | 3.03 16.99% | 3.98 31.35% | 4.57 14.82% | 4.96 8.59% | 5.53 11.35% | 6.18 11.79% |
All data in USD
| Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.26 6.11% | 1.31 5.58% | 1.24 12.78% | 1.40 10.49% | 1.41 11.98% | 1.48 12.94% | 1.35 9.09% | 1.65 17.33% | 1.68 18.57% | 1.67 12.70% |
| Revenue Q2Q % growth | 334.93M -3.91% | 340.74M 3.07% | 340.44M 5.93% | 352.6M 7.72% | 358.08M 6.91% | 362.04M 6.25% | 356.31M 4.66% | 376.52M 6.78% | 379.57M 6.00% | 377.81M 4.36% |
| EBITDA Q2Q % growth | 104.7M -30.28% | 108.28M -37.89% | 108.2M 15.48% | 116.01M -6.66% | 118M 12.70% | 121.66M 12.36% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 89.246M 42.14% | 91.941M 56.49% | 88.444M 36.20% | 98.422M 46.29% | 99.237M 11.19% | 101.59M 10.49% | 93.351M 5.55% | 110.58M 12.35% | 111.84M 12.70% | 110.76M 9.03% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2026 Q2Q % growth | 1.27 13.39% | 1.12 | 0.15 | 13.26% |
| Q1 2026 Q2Q % growth | 1.10 7.84% | 1.03 | 0.07 | 7.20% |
| Q4 2025 Q2Q % growth | 1.24 37.78% | 1.23 | 0.01 | 0.62% |
| Q3 2025 Q2Q % growth | 1.19 14.42% | 1.18 | 0.01 | 0.69% |
| Q2 2025 Q2Q % growth | 1.12 13.13% | 1.08 | 0.04 | 3.35% |
| Q1 2025 Q2Q % growth | 1.02 -2.86% | 1.02 | 0.00 | 0.44% |
| Q4 2024 Q2Q % growth | 0.90 16.88% | 0.90 | 0.00 | -0.02% |
| Q3 2024 Q2Q % growth | 1.04 22.35% | 0.95 | 0.09 | 9.38% |
| Q2 2024 Q2Q % growth | 0.99 19.28% | 0.90 | 0.09 | 10.37% |
| Q1 2024 Q2Q % growth | 1.05 81.03% | 0.74 | 0.31 | 42.31% |
| Q4 2023 Q2Q % growth | 0.77 18.46% | 0.71 | 0.06 | 8.16% |
| Q3 2023 Q2Q % growth | 0.85 1.19% | 0.81 | 0.04 | 4.81% |
| Q2 2023 Q2Q % growth | 0.83 38.33% | 0.68 | 0.15 | 21.95% |
| Q1 2023 Q2Q % growth | 0.58 16.00% | 0.52 | 0.06 | 12.50% |
| Q4 2022 Q2Q % growth | 0.65 41.30% | 0.61 | 0.04 | 7.16% |
| Q3 2022 Q2Q % growth | 0.84 3.70% | 0.74 | 0.10 | 13.25% |
| Q2 2022 Q2Q % growth | 0.60 -3.23% | 0.61 | -0.01 | -1.99% |
| Q1 2022 Q2Q % growth | 0.50 8.70% | 0.45 | 0.05 | 10.01% |
| Q4 2021 Q2Q % growth | 0.46 -33.33% | 0.68 | -0.22 | -32.20% |
| Q3 2021 Q2Q % growth | 0.81 -13.83% | 0.66 | 0.15 | 22.57% |
| Q2 2021 Q2Q % growth | 0.62 -28.74% | 0.51 | 0.11 | 21.42% |
| Q1 2021 Q2Q % growth | 0.46 -43.21% | 0.42 | 0.04 | 10.09% |
| Q4 2020 Q2Q % growth | 0.69 | 0.74 | -0.05 | -6.36% |
| Q3 2020 Q2Q % growth | 0.94 | 0.77 | 0.17 | 22.83% |
| Q2 2020 Q2Q % growth | 0.87 | 0.70 | 0.17 | 23.99% |
| Q1 2020 Q2Q % growth | 0.81 | 0.64 | 0.17 | 26.44% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2026 Q2Q % growth | 327.315M -5.27% | 314.51M | 12.805M | 4.07% |
| Q1 2026 Q2Q % growth | 321.394M -4.40% | 307.42M | 13.974M | 4.55% |
| Q4 2025 Q2Q % growth | 330.599M -3.70% | 332.68M | -2.081M | -0.63% |
| Q3 2025 Q2Q % growth | 348.542M 3.66% | 356.46M | -7.918M | -2.22% |
| Q2 2025 Q2Q % growth | 345.511M 8.59% | 346.07M | -559K | -0.16% |
| Q1 2025 Q2Q % growth | 336.172M 7.98% | 338.73M | -2.558M | -0.76% |
| Q4 2024 Q2Q % growth | 343.29M 12.77% | 332.4M | 10.89M | 3.28% |
| Q3 2024 Q2Q % growth | 336.25M 10.14% | 323.5M | 12.75M | 3.94% |
| Q2 2024 Q2Q % growth | 318.183M 6.95% | 316.25M | 1.933M | 0.61% |
| Q1 2024 Q2Q % growth | 311.332M 19.06% | 295.62M | 15.712M | 5.31% |
| Q4 2023 Q2Q % growth | 304.416M 14.87% | 292.54M | 11.876M | 4.06% |
| Q3 2023 Q2Q % growth | 305.3M 17.51% | 303.47M | 1.83M | 0.60% |
| Q2 2023 Q2Q % growth | 297.5M 24.01% | 271.91M | 25.59M | 9.41% |
| Q1 2023 Q2Q % growth | 261.5M 14.44% | 251.49M | 10.01M | 3.98% |
| Q4 2022 Q2Q % growth | 265M 17.78% | 259.03M | 5.97M | 2.30% |
| Q3 2022 Q2Q % growth | 259.8M 8.07% | 269.41M | -9.61M | -3.57% |
| Q2 2022 Q2Q % growth | 239.9M 14.51% | 243.82M | -3.92M | -1.61% |
| Q1 2022 Q2Q % growth | 228.5M 16.82% | 221.55M | 6.95M | 3.14% |
| Q4 2021 Q2Q % growth | 225M -5.66% | 225.21M | -210K | -0.09% |
| Q3 2021 Q2Q % growth | 240.4M -7.18% | 226.53M | 13.87M | 6.12% |
| Q2 2021 Q2Q % growth | 209.5M -17.06% | 209.73M | -230K | -0.11% |
| Q1 2021 Q2Q % growth | 195.6M -17.99% | 200.26M | -4.66M | -2.33% |
| Q4 2020 Q2Q % growth | 238.5M | 249M | -10.5M | -4.22% |
| Q3 2020 Q2Q % growth | 259M | 257.96M | 1.04M | 0.40% |
| Q2 2020 Q2Q % growth | 252.6M | 252.27M | 330K | 0.13% |
| Q1 2020 Q2Q % growth | 238.5M | 240.09M | -1.59M | -0.66% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -1.43% | 0% | 1.81% |
| Revenue | -0.01% | 0.88% | 0% | 1.84% |